9H5-11394-29829
1 vaccination
1 coded response
4 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 411 / KY
- Registered
- 2021-01-19
- Relationship
- Self
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Moderna
- 2021-01-19
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-01-24
-
2021-01-29
Survey response — day 7, dose 1MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 7, dose 1
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release